Volpara Health Technologies Limited provided revenue guidance for the fiscal year 2023. The company expects Revenue guidance for fiscal year 2023 of NZD 31.5 million to NZD 33 million. That's up from NZD 26 million last year and represents an increase in revenue of between 20% and 25%.
Volpara Health Technologies Limited
Equities
VHT
NZVHTE0001S6
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.145 AUD | +0.44% | -.--% | +3.62% |
05-21 | Volpara Health Technologies Narrows Fiscal 2024 Loss as Revenue Rises 22% | MT |
05-21 | Lunit Implements Scheme to Acquire Volpara Health Technologies | MT |
1st Jan change | Capi. | |
---|---|---|
+3.62% | 194M | |
-3.90% | 29.91B | |
+31.35% | 8.52B | |
+34.03% | 4.21B | |
-29.31% | 2.68B | |
-9.44% | 1.6B | |
-20.44% | 1.37B | |
-34.19% | 1.14B | |
+4.92% | 938M | |
-43.66% | 787M |
- Stock Market
- Equities
- VHT Stock
- News Volpara Health Technologies Limited
- Volpara Health Technologies Limited Provides Revenue Guidance for the Fiscal Year 2023